Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: Results from the I-SPY 1 TRIAL-CALGB 150007/150012, ACRIN 6657

S. Glück

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)281-282
Number of pages2
JournalBreast Diseases
Volume24
Issue number3
DOIs
StatePublished - 2013

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this